Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Tolebrutinib delayed the onset of disability progression by 31% for patients with a type of the disease called non-relapsing ...

Vitamin D is linked to a 34% reduction in the relative risk for disease activity in patients with clinically isolated ...

Pathways to Cures Roadmap was created by a number of MS representatives and was endorsed by more than 30 organizations.

Highly effective MS treatments like monoclonal antibodies and immune-suppressing drugs “may lead to better clinical outcomes ...

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at ages 12-17), and 61% started late ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that ...

New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term ...

STARKVILLE, Miss.—A Mississippi State University researcher is studying a distinct population of coyotes along the Gulf Coast ...